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Abstract
 
The chemokine thymus and activation-regulated chemokine (TARC; CCL17) is displayed by
cutaneous (but not intestinal) venules, and is thought to trigger vascular arrest of circulating
skin homing memory T cells, which uniformly express the TARC receptor CC chemokine re-
ceptor (CCR)4. Cutaneous T cell–attracting chemokine (CTACK; CCL27), expressed by skin
keratinocytes, also attracts cutaneous memory T cells, and is hypothesized to assist in lympho-
cyte recruitment to skin as well. Here we show that chronic cutaneous inflammation induces
CD4 T cells expressing E-selectin binding activity (a marker of skin homing memory cells) in
draining lymph node, and that these E-selectin ligand
 
 
 
 T cells migrate efficiently to TARC
and to CTACK. In 24 h in vivo homing assays, stimulated lymph node T cells from wild-type
mice or, surprisingly, from CCR4-deficient donors migrate efficiently to inflamed skin; and an
inhibitory anti-CTACK antibody has no effect on wild-type lymphocyte recruitment. How-
ever, inhibition with anti-CTACK monoclonal antibody abrogates skin recruitment of CCR4-
deficient T cells. We conclude that CTACK and CCR4 can both support homing of T cells to
skin, and that either one or the other is required for lymphocyte recruitment in cutaneous de-
layed type hypersensitivity.
Key words: lymphocyte homing • chemokines • inﬂammation • delayed type hypersensitivity • 
selectins
 
Introduction
 
There is growing evidence that chemotactic cytokines
(chemokines) contribute to tissue-specific lymphocyte
homing in conjunction with adhesion receptors (1–6). For
example, CC chemokine receptor (CCR)4 on T lympho-
cytes and its ligand thymus and activation-regulated
chemokine (TARC) are implicated in lymphocyte–endo-
thelial interactions during lymphocyte recruitment to nor-
mal and inflamed cutaneous sites (5). Immunohistochemis-
try suggests that TARC is constitutively expressed and
hyperinducible on cutaneous venules and some other sys-
temic venules, but is absent from vessels at sites of lympho-
cyte recruitment into the intestines. Moreover, its receptor
CCR4 is highly expressed by cutaneous lymphocyte anti-
gen positive (CLA
 
 
 
, E-selectin binding) circulating skin
memory lymphocytes, but not by intestinal memory cells,
consistent with a role in tissue selective trafficking. Re-
cently, another skin associated chemokine, cutaneous T
cell–attracting chemokine (CTACK), has been shown to
selectively attract CLA
 
 
 
 cutaneous memory T cells as well.
CTACK is constitutively expressed by epidermal skin kera-
tinocytes and has been postulated to be involved in basal T
cell trafficking during immunosurveillance (6). Inflamma-
tory chemokines that are upregulated in diverse tissue sites
during inflammation, such as ligands for CXC chemokine
receptor (CXCR)3, CCR5, or CCR6, also have the po-
tential to contribute to skin homing. However, the signifi-
cance of these various chemokine/receptor systems to lym-
phocyte recruitment to skin has not been assessed in
physiologic models.
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This study was designed to evaluate the importance of
the CCR4/TARC and CCR10/CTACK in T cell re-
cruitment to inflamed skin in a model of delayed type hy-
persensitivity (DTH) in the mouse. Involvement of
CCR4 was assessed using CCR4-deficient lymphocytes
(7), and that of CTACK using a blocking anti-CTACK
mAb, in short term assays of T cell homing. Our results
reveal that at least one of these pathways (CCR4 or
CCR10/CTACK) must be functional for effective T cell
recruitment to skin; but that, in the setting of DTH, their
involvement is overlapping so that either is permissive for
T cell accumulation. We conclude that in this model of
cutaneous inflammation, these tissue-selective chemokines
play an essential role that cannot be efficiently replaced by
inflammatory chemokines.
 
Materials and Methods
 
Antibodies.
 
Rat anti–mouse antibodies to CTACK (rat
IgG2b), CD44-FITC, CD45RB-PE, CD4-allophycocyanin
(APC), L-selectin-APC, and streptavidin-Cychrome were pur-
chased from BD PharMingen. E-selectin/human IgM chimera
was kindly provided by Dr. Lowe, University of Michigan, Ann
Arbor, MI. Biotinylated goat anti–human IgM was from Caltag.
Monoclonal rat IgG2a anti–human CD44 antibody Hermes-1
(American Type Culture Collection) and 30H12 (anti–mouse
Thy1.2; gift from Dr. Herzenberg, Stanford University, Stanford,
CA) were produced from hybridomas in our laboratories.
 
Animals.
 
C57Bl/6 and CCR4
 
 
 
/
 
 
 
 (7) mice were housed and
bred at the animal facility of Palo Alto Veterans Medical Center.
B6.PL-Thy1.1 mice were obtained from The Jackson Labora-
tory. Mice of both sexes were used at age 8–14 wk.
 
Lymphocyte Isolation.
 
Lymphocytes from skin draining LN
(cervical, and axillary LN) and red cell–depleted splenocytes were
isolated as described (1). Mouse peripheral blood was collected
and lymphocytes were obtained after sedimentation of erythro-
cytes in PBS/5 mM EDTA/2% Dextran for 30 min at 37
 
 
 
C and
further depleted of red blood cells by lysis. Skin-infiltrating T
cells were released from the connective tissue after separating the
epidermal sheets as described (4).
For FACS
 
®
 
 analysis skin infiltrating T lymphocytes were puri-
fied using CD3 selection columns as directed by the manufacturer
(R&D Systems). For chemotaxis assays lymphocytes from skin
draining LN T cells were incubated at 37
 
 
 
C for 1 h before the
assay.
 
Chemotaxis Assay.
 
Standard transmigration assays using 5-
 
 
 
m
pore transwells inserts (Costar) were performed as described (5,
8). Mouse chemokines TARC (CCL17; R&D Systems),
CTACK (CCL27; R&D Systems), macrophage-derived chemo-
kine (MDC; CCL22; PeproTech), and secondary lymphoid tissue
chemoattractant (SLC; CCL21; PeproTech) were used at 100
nM. Input and migrated T cell subsets were identified by their
homing-receptor and activation marker expression using the
E-selectin chimera as well as commercially available monoclonal
antibodies against CD4, CD44, and CD45RB; and percent mi-
gration of antigenically defined subsets was calculated.
 
Flow Cytometry.
 
Identification of E-selectin (CD62E-bind-
ing) ligand (E-lig
 
 
 
) has been assessed by binding with murine
E-selectin Ig chimera, as described (9). In brief, cells were incu-
bated with E-selectin Ig chimera on ice for 30 min. Nonspecific
staining was determined by addition of 5 mM EDTA. Cells were
washed and biotinylated goat anti–human IgM was adminis-
tered. After blocking with 10% rat IgG, cells were stained with
streptavidin-Cychrome, CD44-FITC, CD45RB-PE, and CD4-
APC. For homing studies, Thy1.2-FITC and CD4-APC were
used. Cells were analyzed using CELLQuest™ software (Becton
Dickinson).
 
Immunohistochemistry.
 
Acetone fixed frozen sections of
mouse ears (6 
 
 
 
m) were blocked with 50% rat IgG before incu-
bation with 20 
 
 
 
g/ml rat anti–mouse CD4-PE (R&D Systems)
and 20 
 
 
 
g/ml rat anti–mouse Thy1.2-FITC and visualized by
confocal microscopy. Stained sections from Thy1.1 recipients of
Thy1.2
 
 
 
 donor cells of wild-type or CCR4
 
 
 
/
 
 
 
 origin were an-
alyzed by counting the total number of CD4 T cells, and the
number of Thy1.2
 
  
 
CD4 T cells in 
 
 
 
20 optical fields (40
 
 
 
 ob-
jective); at least 150 Thy1.2
 
  
 
CD4 T cells were counted for
each recipient type. Mice that received no donor cells served as
staining controls. Data represent mean 
 
  
 
SEM of CD4 or
Thy1.2
 
  
 
CD4 T cells per optical field of three independent ex-
periments.
 
DTH.
 
DTH reaction was induced by repeated epicutaneous
application of 2,4 dinitrofluorobenzene (DNFB; Sigma-Aldrich)
(10). Primary immunization was achieved by painting bare ab-
dominal skin on day 1 with 0.5% DNFB (20 
 
 
 
l, in acetone:olive
oil, 4:1). On day 7, mice were challenged by application of 0.5%
DNFB (20 
 
 
 
l) on the ears to create a secondary DTH response
and lymphocytes draining the inflamed skin (from cervical, and
axillary LN) were collected 24 h later and used as donor cells for
adoptive transfer studies. Congenic recipients did not receive pri-
mary immunization and were challenged only (20 
 
 
 
l of 0.5%
DNFB on both ears) just after transfer of donor cells. Ear thick-
ness (measured with Ames calipers) was measured at the time of
challenge (0 h, baseline) and at 24 h after donor cell (or no donor
control) administration and ear painting, and the difference
(swelling) was calculated. Donor cell–dependent swelling was the
difference between swelling of ears of donor cell recipients, and
of “no donor control” mice.
 
Adoptive Transfer/Homing Assay.
 
The in vivo homing of
wild-type and CCR4
 
 
 
/
 
  
 
lymphocytes to inflamed skin was com-
pared using the Thy1 congenic system. B6.Thy1.1 mice were
used as recipients, whereas CCR4
 
 
 
/
 
 
 
 and C57Bl/6 T cells
(Thy1.2 allotype) served as donor T cells. 5–10 
 
 
 
 10
 
7
 
donor T
cells, obtained from LN draining the inflamed skin 24 h after the
DNFB treatment on day 7 of initially primed animals (described
above), were retro-orbitally injected into unprimed congenic re-
cipients in 100–200 
 
 
 
l saline (after labeling with 500 nM CFSE
for proliferation studies). Immediately after the adoptive transfer
both ears of the unprimed recipients were challenged with the
immunogen (20 
 
 
 
l of 0.5% DNFB) to create a “secondary” im-
mune response mediated by the transferred donor cells. Homing
of adoptively transferred lymphocytes to skin and other organs
was evaluated after 24 h (control animals received no donor cells).
The readout for DTH was ear swelling (see above). Additionally,
FACS
 
®
 
 analysis was performed to identify donor-derived
CD4 T cells as described. To assess the role of CTACK, 100 
 
 
 
g
(2 mg/ml) monoclonal rat anti–mouse CTACK antibody was in-
jected twice intravenously (6 and 1 h in advance of donor cell in-
jection). Control animals were treated with isotype control anti-
body, Hermes 1 (American Type Culture Collection). Data are
expressed as the relative number of donor T cells (percent
Thy1.2
 
 
 
 in CD4 population) in each tissue normalized to that of
donor T cells in draining LN (to facilitate comparisons between
experiments). The data presented are the mean 
 
  
 
SEM of results
from seven experiments. 
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Statistical Analysis.
 
For statistical comparison of two samples,
a two-tailed Student’s 
 
t
 
 test was used when applicable.
 
Results and Discussion
 
E-lig
 
 
 
 T Cells Induced during Cutaneous Inflammation Mi-
grate to TARC, MDC, and CTACK.
 
T cells are essential
participants in pathologic cutaneous inflammatory reactions
including contact hypersensitivity, and inflammatory disor-
ders such as psoriasis and atopic dermatitis. T cells recruited
in these diverse disorders share a number of common fea-
tures, associated with important mechanisms for tissue se-
lective homing to skin. These include expression of high
levels of the E-selectin binding cutaneous lymphocyte anti-
gen (10–12) and, based on recent studies, expression of the
chemokine receptors CCR4 and probably CCR10 (5, 6).
Although binding to vascular E-selectin has been shown to
be important for T cell recruitment and T cell–mediated
inflammation in skin in physiologic models (10, 13), in-
volvement of CCR4 and its vascular ligand TARC, and of
CTACK and its lymphocyte receptor CCR10 in skin lym-
phocyte homing have been proposed based on indirect if
compelling studies of their patterns of expression in vivo
and their proadhesive/or chemotactic activities in vitro.
The present study was designed to assess directly the in-
volvement of these chemokine/receptor pairs in physio-
logic assays of T cell homing to inflamed skin.
We initially asked whether skin homing T cells in the
mouse (as in the human), migrate efficiently to TARC and
CTACK. As determined by FACS
 
®
 
 analyses, only 
 
 
 
3% of
T cells in normal LN bind E-selectin; but E-lig
 
 
 
 memory
T cells (CD4
 
 
 
CD44
 
high
 
CD45RB
 
low
 
) are abundant in skin
inflamed by application of DNFB (36 
 
 
 
 6% of skin CD4
memory T cells; 
 
n 
 
  
 
6) and in LN draining inflamed skin
(12 
 
 
 
 3%, 
 
n
 
 
 
  
 
6; Fig. 1 a). Importantly, induction of
E-lig
 
 
 
 T cells in LN, and the accumulation of T cells and
the frequency of E-lig
 
 
 
 T cells in inflamed ears, were not
substantially altered in CCR4-deficient mice (13 
 
 
 
 3% in
draining LN, and 50 
 
 
 
 5% in inflamed skin, 
 
n
 
 
 
  
 
6; Fig. 1
b). The fraction of CD4 T cells of memory phenotype
(CD44
 
high
 
CD45RB
 
low
 
) in skin-draining LN was also simi-
lar (Fig. 1 c), representing 10 
 
 
 
 1% and 12 
 
 
 
 1% (mean 
 
 
 
SEM, 
 
n
 
 
 
  
 
10) of the CD4 pool in both wild-type and
CCR4
 
 
 
/
 
 
 
 mice. In conclusion, our experiments show that
CCR4 is not required for induction of memory T cells
with skin homing (E-lig
 
 
 
) phenotype, nor for the accumu-
lation of T cells in inflamed skin.
In transwell chemotaxis assays, the E-lig
 
 
 
 subset of T cells
derived from draining LN migrates efficiently to CCR4
ligands TARC and MDC. Migration is selective, in that the
E-lig-memory phenotype T cells (and naive T cells) re-
spond relatively poorly to the CCR4 ligands (Fig. 2 a),
though they migrate well to the CCR7 ligand SLC (Fig. 2
a). Migration to TARC and MDC is CCR4 dependent, as
Figure 1. Generation of E-lig 
CD4 memory T cells after cuta-
neous immunization with
DNFB. T lymphocytes from
draining LN and inflamed skin of
wild-type (a) and CCR4 / 
mice (b) treated with immuno-
gen (DNFB) were isolated and
analyzed by flow cytometry for
E-lig  expression in comparison
to LN cells from untreated mice.
Induction of E-lig  T cells in
LN, and the localization of E-lig 
T cells in inflamed ears, were not
significantly altered in CCR4-
deficient mice (b). The fraction
of CD4 T cells of memory phe-
notype in skin-draining LNs was
also similar (c). T cells are gated
on memory T cells (CD4 
CD44highCD45RBlow). Addi-
tional controls (E-selectin Ig chi-
mera     EDTA on LN cells)
were also negative (not shown).
The data are representative of 6
(a and b) and 10 (c) experiments. 
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T cells from CCR4-deficient mice do not respond to these
CCR4 ligands, but retain their responsiveness to SLC (Fig. 2
b). In addition, both wild-type and CCR4-deficient E-lig
 
 
 
but not E-lig- CD4 memory T cells migrate to CTACK
(Fig. 2, c and d). Thus CTACK, as well as TARC and
MDC, attract E-lig
 
 
 
 memory T cells in mouse, as in man.
 
CCR4-deficient Lymphocytes Home Efficiently to Inflamed
Skin.
 
We next wanted to assess the physiologic impor-
tance of CCR4 for lymphocyte homing to cutaneous in-
flammatory sites (Fig. 3). To this end, we adoptively trans-
ferred wild-type C57Bl/6 and CCR4
 
 
 
/
 
 
 
 donor T cells
expressing the Thy1.2 marker into B6.Thy1.1 recipients
whose ears were stimulated by painting with DNFB at the
time of cell transfer. Donor T cells were obtained from LN
draining sites of DTH (24 h after elicitation), to enhance
the numbers of E-lig
 
 
 
, skin homing T cells transferred.
24 h after transfer, recipient LN, spleen, blood, and skin
lymphocytes were isolated, and the percentage of CD4 T
cells expressing the donor Thy1.2 allotype was determined
by FACS
 
®
 
. To facilitate comparisons between experiments,
homing to different organs was normalized to the homing
of donor T cells to LN (primarily naive cells; 
 
 
 
80%
L-selectin
 
 
 
 in both wild-type [81 
 
 
 
 1%, mean 
 
  
 
SEM,
 
n
 
 
 
  
 
3] and CCR4
 
 
 
/
 
 
 
 donors [81 
 
 
 
 2%, mean 
 
  
 
SEM,
 
n
 
 
 
  
 
3]; Fig. 3 b).
As shown in Fig. 3 a (left panel), donor preimmunized
LN T cells localized more efficiently than endogenous
(non-presensitized) host T cells to inflamed skin: although
donor T cells comprised on average only 
 
 
 
5 
 
 
 
 1% of total
LN CD4 cells in recipients’ LN (with no significant differ-
ence between wild-type and CCR4
 
 
 
/  donors) 24 h after
adoptive transfer, they represented up to 50% ( 15–50%)
of T cells in DNFB painted ears. Surprisingly, preimmu-
nized CCR4 /  T cells accumulated in skin at least as well
(Fig. 3 a, right panel) as wild-type immunized T cells. At
this 24 h time point after transfer, accumulation of donor
cells is likely dominated by recruitment from the blood, al-
though transit time and recirculation into draining lymph
may also contribute. Proliferation of homed cells can con-
tribute to local cell numbers in inflammation, as well, but
CFSE labeling of donor cells revealed that few LN- or
skin-homing T cells had undergone division in the course
of our experiments (Fig. 3 c).
The ability of CCR4 /  T cells to home efficiently to
skin was unexpected, and suggested either that CCR4 is
not involved in lymphocyte recruitment to inflamed skin,
or that its role(s) can be fulfilled by other chemokines act-
ing in parallel in a redundant fashion.
Effect of Anti-CTACK Antibody on T Cell Recruitment to
Skin. To determine if CTACK mediates T cell recruit-
ment in the DTH model, we administered an inhibitory
anti-CTACK mAb before the transfer of Thy1.2  donor
cells. As shown in Fig. 4 a, the anti-CTACK antibody had
no effect on the fraction of ear localized CD4 cells of wild-
type donor origin. Surprisingly, however, administration of
anti-CTACK mAb dramatically reduced the skin localiza-
tion of CCR4-deficient T cells (Fig. 4 b). Administration
of the isotype control mAb had no effect on wild-type or
CCR4-deficient T cell recruitment to the skin (data
pooled from experiments with control mAb (n   3) and no
pretreatment of recipients (n   4; Fig. 3 a).
In addition, we used immunohistology as an indepen-
dent means to assess the relative and absolute localization of
donor cells in recipients’ ears. Immunofluorescence stain-
ing revealed no significant difference in the number of
Thy1.2  CD4 wild-type donor cells localizing in inflamed
ears after treatment with anti-CTACK antibody compared
with the control mAb (6   0.4 versus 5   0.4 Thy1.2 
CD4 T cells per 40  microscope field; mean   SEM, n  
3). Importantly, the number of Thy1.2  CD4 cells of
Figure 2. Migration of E-lig  CD4
memory T cells to TARC, MDC, and
CTACK. T lymphocytes from LN draining
a cutaneous DTH site were isolated and mi-
grated to TARC, MDC, CTACK, or SLC
in a transwell chemotaxis assay (background
migration to medium alone is subtracted).
Both, E-lig  and E-lig  wild-type (a) and
CCR4 /  (b) CD4 memory T cells migrate
equally well to SLC. Chemotaxis to MDC
and TARC correlates with E-lig  expres-
sion and is CCR4 dependent as CCR4 / 
cells do not respond (a and b). Similarly,
E-lig  but not E-lig  wild-type and
CCR4 /  CD4 memory T cells are at-
tracted by CTACK (c and d). The data are
mean     SEM of three to seven experi-
ments.1545 Reiss et al.
CCR4 /  origin was greatly reduced in anti-CTACK
treated recipients (by 77%: 2   0.5 CCR4 /  Thy1.2 
CD4 T cells per 40  field in anti-CTACK treated recipi-
ents, versus 7   0.7 cells per field in control mAb treated
animals; mean   SEM, n   3). In addition, we observed
no significant differences in the numbers of total (donor
plus host) CD4 T cells in the inflamed recipient skin after
administration of anti-CTACK (in recipients of wild-type
cells, there were 61   7 total CD4 T cells per field after
anti-CTACK treatment, compared with 68   2 CD4 T
cells after control mAb treatment; in recipients of CCR4 / 
donor cells 64   5 and 61   10, respectively; mean  
SEM, n   3). Thus, anti-CTACK treatment had little or
no effect on endogenous CD4 T cell numbers in skin. We
Figure 3. CCR4 is not essential for T cell
homing to inflamed skin in DTH. Adoptively
transferred wild-type and CCR4 /  donor T
cells (Thy1.2 ) home with the same efficiency
to the inflamed skin of Thy1.1 recipients (a).
Background (false Thy1.2  cells in recipients
with no donor cells,  0.2%) has been sub-
tracted. Data are percentage of donor
(Thy1.2 ) T cells among CD4 T cells, normal-
ized to LN values (mean   SEM of seven ex-
periments). Donor Thy1.2  CD4 cells ranged
from 2 to 10% of LN CD4 cells in the different
experiments presented here. SPL, spleen. (b)
L-selectin staining of wild-type and CCR4 / 
donor LN T cells (primarily naive cells; repre-
sentative results, n   3). (c) CFSE labeling of
donor cells revealed that few LN- or skin-hom-
ing T cells had undergone division in the course
of our experiments.
Figure 4. Anti-CTACK antibody inhibits donor
CCR4 /  but not wild-type T cell recruitment to in-
flamed skin. Administration of anti-CTACK mAb (a)
or control irrelevant antibody (not shown) had no ef-
fect on the percentage of adoptively transferred wild-
type donor T cells (Thy1.2 ) among skin CD4 cells
(compared with panel a). In contrast, anti-CTACK
dramatically inhibits skin homing of CCR4-deficient
lymphocytes (b). Data are percentage of donor
(Thy1.2 ) T cells among CD4 T cells in each tissue,
normalized to LN values (mean   SEM of seven ex-
periments). The proportion of donor Thy1.2  CD4
cells among LN CD4 cells (which defines a relative lo-
calization of 100% in each experiment) ranged from 1
to 13%.1546 CCL27/CCR10 and CCR4 in Skin Lymphocyte Homing
conclude that the effect of anti-CTACK antibody on lym-
phocyte homing is specific in that the antibody had little or
no effect on wild-type lymphocyte homing to skin, or on
CCR4 /  or wild-type lymphocyte homing to other or-
gans; and it is potent, in that it dramatically reduces CD4 T
cell homing to skin in the absence of CCR4.
Consequently, as for CCR4, CTACK is not essential for
lymphocyte homing to skin: only simultaneous inhibition
of CCR4 and CTACK (CCR10) responses effectively
blocks lymphocyte recruitment. We conclude that memory
T cell recruitment to inflamed skin requires either CCR4
or CTACK participation, but that either pathway (CCR4/
TARC or CCR10/CTACK) alone can mediate efficient T
cell accumulation over the 24 h recruitment period.
Effect of Anti-CTACK on T Cell–dependent Ear Swelling
Induced by Adoptive Transfer of Wild-Type or CCR4-deficient
Lymphocytes. Adoptive transfer of immunized LN cells
confers T cell-dependent enhanced ear swelling, the hall-
mark of DTH, in response to DNFB challenge (14). To
determine if this T cell–dependent swelling requires CCR4
or CTACK, the ability of CCR4-deficient lymphocytes to
mediate swelling, and the effect of anti-CTACK mAb on
wild-type and CCR4-deficient donor T cell–mediated re-
sponses was assessed (Fig. 5). Paralleling the results for
T cell homing, neither CCR4 deficiency of transferred LN
cells, nor anti-CTACK mAb in the setting of wild-type
cell transfer, substantially inhibited swelling. However,
anti-CTACK dramatically and consistently inhibited swell-
ing induced by CCR4-deficient cells.
The simplest interpretation of our studies is that both
CCR4 and its ligands, and CTACK and its receptor
CCR10, play overlapping and redundant roles in T cell re-
cruitment into the inflamed ear, potentially mediating both
arrest of T cells rolling on cutaneous endothelium, and ex-
travasation of arrested T cells in response to an extravascu-
lar gradient. Immunohistochemically defined display of
TARC by cutaneous venules, in combination with the
ability of CCR4 ligands to trigger CLA  T cell adhesion
(5), has led us to propose that CCR4 can trigger the inte-
grin-dependent arrest of lymphocytes rolling on cutaneous
venules in vivo. However CCR4 ligands, especially MDC,
can be highly expressed by activated macrophages and
other cells within tissues, so that existence of a gradient of
CCR4 ligands capable of supporting extravasation of endo-
thelial bound T cells has not been excluded. Conversely,
CTACK is highly and selectively expressed by kerati-
nocytes, leading to the hypothesis that CTACK might sup-
port diapedesis and epidermotropism of skin homing T cells
(6, 15). However, chemokines can be transported across
endothelium to participate in leukocyte arrest (2, 16, 17);
thus, keratinocyte-derived CTACK may also have a role at
the vascular lumen. Roles in retaining homed cells in the
inflamed ear are possible, as well. Novel techniques permit-
ting in situ analyses of T cell interactions in inflamed ears
will be required to determine precisely the level(s) at which
CCR4, CTACK, and inflammatory chemokines participate
in the process of lymphocyte recruitment. Importantly, our
results also indicate that inflammatory chemokines induced
in this model of cutaneous inflammation cannot by them-
selves support efficient recruitment of T cells.
In conclusion, our studies directly demonstrate the in-
volvement of tissue-selective chemokine/receptor path-
ways - CCR4 and its ligands, and CTACK, presumably
acting through its receptor CCR10 - in lymphocyte re-
cruitment to skin and in cutaneous inflammation. Our
findings suggest further that, in some models of cutaneous
inflammation, these chemokine/receptor pathways can ef-
ficiently substitute for each other, but that either one or the
other is required. Of course, the relative importance of
CCR4 and CCR10 (and the extent of their redundancy)
during skin lymphocyte homing may vary under different
circumstances. Inhibition of these pathways, singly or in
combination, may offer a novel approach to therapeutic
modulation of cutaneous inflammatory disorders.
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